|
The ABCD
End-OSA study
is a single centre investigational study assessing the
effectiveness of a new medical device called Endobarrier in
patients with obstructive sleep apnoea and diabesity. The
recruitment was started in March 2016.
This study has been funded and
initiated by ABCD, supported by NHS as one of the NIHR
portfolio studies. The STUDY HAS
BEGUN when first patient recruited into the study
received her Endobarrier on 3 June 2016. This triggered a
BBC news item which is available to view.
|
